Pilot study of topical imiquimod combined with pembrolizumab for unresectable cutaneous metastatic melanoma

• by Joseph B. Parker, Richard W. Joseph, Vera J. Suman, Yiyi Yan, Ruqin Chen

• June 10, 2026

Durable response to ALK inhibition in low-allele-frequency SPTBN1–ALK–rearranged gastric cancer followed by lineage plasticity–mediated resistance: a case report

• by Zihua Guan, Jiao Liu, Wenlu Yu, Xu Wang, Xinmei Zhang

• July 21, 2026

The Secrets of the Gut

Going beyond the gut: why microbiome testing is the next big thing in drug development

• by Christina Casén

• July 20, 2026

• 6 min

Circadian rhythms in the tumor microenvironment: spatiotemporal immune regulation and chronotherapeutic opportunities

• by RenJie Zhao, YuXuan Xiao, XingXing Fan

• July 21, 2026